Elevance Health Inc. (ELV) ownership: insiders 0% · institutions 92% (13F 2026-03-31). Insider activity, 90 days: Insiders bought (2 sales, 3 open-market buys). 10 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Vanguard | 23028013.00 | $6.74B | 10.6% | 2026-03-31 |
| BlackRock | 19887111.00 | $5.82B | 9.2% | 2026-03-31 |
| State Street | 10288696.00 | $3.01B | 4.7% | 2026-03-31 |
| Wellington Management | 8229241.00 | $2.41B | 3.8% | 2026-03-31 |
| Sanders Capital, LLC | 5894303.00 | $1.73B | 2.7% | 2026-03-31 |
| Geode Capital Management | 5192707.00 | $1.51B | 2.4% | 2026-03-31 |
| Artisan Partners | 5127175.00 | $1.50B | 2.4% | 2026-03-31 |
| Invesco | 4817410.00 | $1.41B | 2.2% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-07-17 | |
| Buy | null | 2026-07-17 | |
| Buy | null | 2026-07-17 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 |
Back to ELV overview · ELV earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.